Cellartgen aims to achieve personalized regenerative medicine through the fusion of organoid and biomaterial technologies.
Biomedical science and technology are developing rapidly, but many people are still suffering from intractable and rare diseases.
Cellartgen aims to develop treatments for these rare and intractable disease through utilizing state-of-the-art biotechnologies that combine both the use of organoids and biomaterials, and further develop regenerative medicines for damaged organs to give many people a chance to live a full life.
All Cellartgen members are grounded in values based on mutual respect and cooperation with each other.